Award recordCONTRACT

EXELAN PHARMACEUTICALS INC

PIID 36C25726N0241· VHA· 257-NETWORK CONTRACT OFFICE 17 (36C257)· Q509 · FAMILY & INTERNAL MEDICINE SERVICES· FY2026· $899,347 net obligations· UEI FYZXNHSQTMG8· FL

Description

PERIOD OF PERFROMANCE EXTENDED-LENALIDOMIDE ORAL MED

Base award description: LENALIDOMIDE ORAL MED

First action · last action
2026-02-05 · 2026-03-27
Transactions
2
First transaction's obligation
$899,347
Base + all options value (sum of deltas)
$899,347
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0227
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$899,347$0Base award · 2026-02-05 · this action $899,347 · running total $899,347Modification P00001 · 2026-03-27 · this action $0 · running total $899,347
  • Base2026-02-05+$899,347= $899,347
  • Mod P000012026-03-27+$0= $899,347
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2026-02-05+$899,347$899,347LENALIDOMIDE ORAL MED
Mod P00001· OTHER ADMINISTRATIVE ACTION2026-03-27+$0$899,347PERIOD OF PERFROMANCE EXTENDED-LENALIDOMIDE ORAL MED

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FYZXNHSQTMG8)

AwardOffice · PSC / listingNet obligationsFY
36C24226N0564242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$5,337,256FY2026
36C25926F0197NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$1,844,059FY2026
36C26026F0261260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$918,831FY2026
36E79726D0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0169260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$712,808FY2026
36C24426N0400244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$1,487,248FY2026

Other recipients under Q509 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25726A0036MILLBROOK TFG LLC257-NETWORK CONTRACT OFFICE 17 (36C257)$0FY2026
36C25724N0116UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO257-NETWORK CONTRACT OFFICE 17 (36C257)$0FY2024
36C25724N0076UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO257-NETWORK CONTRACT OFFICE 17 (36C257)$13,769FY2024
36C25723C0012JADE WOLF OPERATIONS, LLC257-NETWORK CONTRACT OFFICE 17 (36C257)$14,351,033FY2023
36C25723N0093UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO257-NETWORK CONTRACT OFFICE 17 (36C257)$17,345FY2023

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25726N0241_3600_36F79720D0227_3600 · retrieved 2026-09-26.